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1. Introduction
   Diabetes mellitus poses a major health problem on both 
clinical and social plan, not only for the high number 
of patients, but also for the onset of serious invaliding 
complications that frequently appear[1]. It is a prototypical, 
growing, costly chronic non-communicable disease 
causing increasing morbidity and mortality worldwide, 
often disproportionately hurting the poor and young sub-
populations in developing countries[2]. More than 220 
million people worldwide are affected by Diabetes and its 
incidence is expected to increase to 400 million by 2030[3]. 
About 95% of diabetic patients suffer from type2 diabetes. 
Diabetes is chronic, multifaceted, dynamic expression 
of pathological disequilibria, resulting in various micro 
and macro vascular complications. The pathophysiology 
of diabetes involves a very complex cascade of several 
interrelated mechanism. The chronic hyperglycemia of 
diabetes is associated with long term damage, dysfunction 
and failure of various organs, especially the eyes, kidneys, 
nerves, heart and blood vessels[4].
   Glycoproteins can be simply defined as proteins 
that have carbohydrate moiety covalently attached to 
their peptide portion. They have multiple and complex 
function and are found as enzymes, hormones, blood 
group substances and as constituents of extracellular 
membranes[5]. The commonest glycoproteins are those in 
which the carbohydrate is linked to the protein by glycosyl 
linkages, usually hexose, hexosamine, fucose and sialic 
acid, joined together covalently linked to polypeptide 
chain. Hyperglycemia in experimental diabetic rats 
leads to a decreased utilization of glucose by insulin 
dependent pathways, thereby enhancing the formation of 
glycoproteins[6]. At the cell surface or inside the cells, the 
glycoprotein components such as fucose and sialic acid 
form specific structures, called glycanic chains covalently 
linked to lipids or proteins. An increase in the biosynthesis 
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or a decrease in the metabolism of glycoproteins could be 
related to the deposition of these materials in the basal 
membrane of pancreatic cells. Alterations in glycoproteins 
level leads to the pathogenesis of diabetes mellitus. Many 
studies confirm the involvement of glycoproteins in diabetic 
complications[7].
   Experimental induction of diabetes mellitus in animal 
models is essential for understanding various aspects of its 
pathogenesis and ultimately finding new therapies and cure. 
Several methods have been used to induce diabetes mellitus 
in laboratory animals with variable success. Streptozotocin 
(STZ), an antibiotic produced by Streptomyces achromogenes, 
has been widely used for inducing diabetes in the 
experimental animals through its toxic effects on pancreatic 
β-cells[8]. In recent years, there has been a growing 
interest in anti-diabetic agents from natural products. They 
represent an alternative mode for diabetes therapy because 
most of the anti-diabetic drugs have some side effects and 
fail to significantly alter the course of the disease. Terpenes 
are the largest group of natural substances, biosynthetically 
derived from isoprene units[9]. They are abundantly found 
in fruits, vegetables and aromatic and medicinal plants. 
Moreover, they are endowed with many beneficial health 
effects and can be used to treat different health disorders 
including diabetes[10]. Monoterpenes are naturally 
occurring hydrocarbons composed of the condensation 
of two isoprenes. They are widely distributed in the plant 
kingdom and are best known in plant essential oils. Carvone 
(5-isopropenyl-2-methyl-2-cyclohexenone), a monocyclic 
monoterpene ketone, is produced by over 70 different plants. 
It is the main component of caraway oil. This monoterpene 
exhibits some interesting biological activities. It shows, for 
instance, antimicrobial[11], nematicidal[12] and antitumor 
properties[13]. 
   The aim of the present study was experimentally to 
validate the neutraceutical potential of carvone in the 
management of diabetes and also mediated through its 
salubrious effect on plasma and tissue glycoproteins in 
STZ-induced diabetic rats and the efficacy of carvone was 
compared with glyclazide, a standard oral antihyperglycemic 
drug. The outcome would provide important information 
about its usefulness as a therapeutic agent for the treatment 
of diabetes and related complications.
2. Materials and methods
2.1. Chemicals
   Carvone and STZ were procured from Sigma Chemicals 
Co., St. Louis, MO, USA, stored at 2-4 °C and protected from 
sunlight. All other chemicals were of analytical grade and 
were obtained from standard commercial suppliers.
2.2. Animals
   Male Wistar rats weighing approximately 180-200 g were 
grown in the Central Animal House, Rajah Muthiah Medical 
College, Annamalai University, India. Before starting 
the experiments all the animals were acclimatized to the 
laboratory conditions for 1 week. They were housed at an 
ambient temperature of (25依2) °C, 12/12 h of light–dark 
cycle with ad libitum food and water. All animals used in 
this study were cared for according to the Care and Use of 
Laboratory Animals Guidelines by Ministry of Social Justices 
and Empowerment, Government of India. The study protocol 
was approved (Reg No.160/1999/CPCSEA, Vide No. 986/2012) 
by the Committee for the Purpose of Control and Supervision 
on Experimental Animals at Annamalai University, 
Annamalainagar, India.
2.3. Induction of diabetes
   Diabetes was induced in overnight fasted experimental 
rats by a single intraperitoneal injection of STZ (40 mg/
kg b.w) dissolved in freshly prepared citrate buffer (0.1 M, 
pH 4.5). STZ injected animals were allowed to drink 20% 
glucose solution overnight to overcome the initial drug-
induced hypoglycemic mortality. Control rats were injected 
with same volume of citrate buffer alone. After 96 h, plasma 
glucose was determined and those rats with fasting blood 
glucose greater than 250 mg/dL were used in the present 
study.
2.4. Experimental design
   The animals were randomly divided into seven groups 
of six animals in each group (30 diabetic surviving and 12 
normal). Carvone was dissolved in vehicle solution of corn 
oil and administered to experimental rats.
Group I Normal control (vehicle treated)
Group II
Normal rats received carvone (100 mg/kg b.w)  intra 
gastrically suspended in 1 mL corn oil for 30 d
Group III Diabetic control 
Group IV
Diabetic rats received carvone (25 mg/kg b.w) intra 
gastrically suspended in 1 mL corn oil for 30 d
Group V
Diabetic rats received carvone (50 mg/kg b.w) intra 
gastrically suspended in 1 mL corn oil for 30 d
Group VI
Diabetic rats received carvone (100 mg/kg b.w) intra 
gastrically suspended in 1 mL corn oil for 30 d
Group VII
Diabetic rats received glyclazide (5 mg/kg b.w) intra 
gastrically in aqueous solution for 30 d
   During the experimental period, body weight, blood 
glucose, food and water consumption and physical 
examinations were determined at regular intervals. The 
dosage was adjusted every week according to any change 
in body weight to maintain similar dose per kg body weight 
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of rat over the entire period of study for each group. At the 
end of the treatment period, the rats were fasted overnight, 
anaesthetized with ketamine (24 mg/kg body weight; i.p.) 
and killed by cervical decapitation. Blood sample was 
collected in a tube containing potassium oxalate and sodium 
fluoride (3:1) for the estimation of plasma glucose, insulin 
and glycoproteins. Liver and kidney were dissected out, 
washed in ice-cold saline, patted dry and weighed.
2.5. Extraction of glycoproteins
   To 0.1 mL of plasma, 5.0 mL of methanol was added, mixed 
well and centrifuged for 10 min at 3 000×g. The supernatant 
was decanted and the precipitate was again washed with 
5.0 mL of 95% ethanol, recentrifuged and the supernatant 
was decanted to obtain the precipitate of glycoproteins. 
This was used for the estimation of hexose and hexosamine. 
For extraction of glycoproteins from the tissues, a known 
weight of the tissue was homogenized in 7.0 mL of 
methanol. The contents were filtered and homogenized with 
14.0 mL of chloroform. This was filtered and the residue was 
successively homogenized in chloroform-methanol (2:1 v/v) 
and each time the extract was filtered. The residue (defatted 
tissues) was obtained and the filtrate decanted. A weighed 
amount of defatted tissue was suspended in 3.0 mL of 2 N 
HCl and heated at 90 °C for 4 h. The sample was cooled and 
neutralized with 3.0 mL of 2 N NaOH. Aliquots from this 
were used for estimation of fucose, hexose, hexosamine and 
sialic acid.
2.6. Estimation of blood glucose and plasma insulin
   Blood glucose was determined spectrophotometrically 
using a commercial diagnostic kit Agappe Diagnostics Pvt 
Ltd., India) by the method of Trinder[14]. Plasma insulin was 
assayed by ELISA using a Boehringer–Mannheim kit with 
an ES300 Boehringer analyzer (Mannheim, Germany). Both 
the analyses were done according to the manufacturer’s 
instructions.
2.7. Determination of glycoproteins
   The plasma and tissue hexose content was estimated by 
the method of Niebes[15], sialic acid in plasma and tissues 
were estimated by the method of Warren[16] and hexosamine 
by the method of Wagner[17]. Fucose was estimated by the 
method of Dische and Shettles[18]respectively.
2.8. Statistical analysis
   The values are expressed as mean values of six rats in 
each group±standard error mean (S.E.M). Data analysis was 
done with SPSS 17.0 (SPSS, Cary, NC, USA) student software. 
Hypothesis testing method included one way analysis of 
variance (Anova) followed by Duncan’s Multiple Range Test 
(DMRT)[19]. Values are considered statistically significant 
when P<0.05.
3. Results 
3.1. Effect of carvone on the levels of plasma glucose and 
insulin 
   Table 1 showed the levels of plasma glucose and insulin 
in normal control and experimental rats. The level of plasma 
glucose as significantly increased whereas plasma insulin 
level was significantly decreased in diabetic control rats. 
Administration of carvone (all doses), as well as glyclazide 
brings a significant decrease in plasma glucose and increase 
in insulin level were observed at the end of the experimental 
period. Carvone at a dose of 50 and 100 mg/kg b.w showed 
a highly significant effect than other dose (25 mg/kg b.w). 
Based on these data, the effective dose was fixed as 50 mg/kg 
b.w. and used for further analysis.
Table 1. 
Effect of carvone on the levels of plasma glucose and insulin in control and 
experimental rats.
Groups
Plasma glucose 
(mg/dL)
Plasma insulin 
(µU/mL)
Normal control 78.20依5.95* 16.24依1.24*
Normal + carvone (100 mg/kg) 77.95依5.97* 16.43依1.26*
Diabetic control 295.23依22.48†   6.91依0.53†
Diabetic + carvone (25 mg/kg) 143.78依11.01‡ 10.06依0.81‡
Diabetic + carvone (50 mg/kg) 115.33依8.83**  13.63依1.04**
Diabetic + carvone (100 mg/kg) 111.57依8.54**  13.99依1.07**
Diabetic + glyclazide (5 mg/kg)  103.32依7.91***   14.34依1.10***
Values are given as means依S.D. for six rats in each group. Values in a column 
not sharing a common superscript symbol (* -***) differ significantly at 
P<0.05. Duncan’s Multiple Range Test (DMRT).
3.2. Effect of carvone on the levels of plasma glycoproteins
 Table 2. 
Effect of carvone on plasma glycoprotein levels in normal and experimental rats (mg/dL).
Groups Hexose Hexosamine Fucose Sialic acid
Normal control    96.20依7.32*   72.20依5.50* 34.73依2.64* 55.85依4.27*
Normal + carvone (50 mg/kg)    93.97依7.19*   70.58依5.40* 32.83依2.51* 54.34依4.14*
Diabetic control   162.36依12.36† 101.29依7.75† 51.28依3.90† 82.94依6.35†
Diabetic + carvone (50 mg/kg) 115.33依8.83‡   88.29依6.76‡ 42.93依3.29‡ 63.66依4.85‡
Diabetic + glyclazide (5 mg/kg) 107.31依8.21‡   80.33依6.15‡ 38.28依2.93‡ 60.37依4.62
Values are given as means依S.D. for six rats in each group. Values in a column not sharing 
a common superscript symbol (* -‡) differ significantly at P<0.05. Duncan’s Multiple Range 
Test (DMRT).
   Table 2 shows the changes in the levels protein bound 
hexose, hexosamine, fucose and sialic acid in plasma of 
control and experimental rats. Significantly higher levels 
of glycoprotein components were observed in the plasma 
of diabetic rats when compared to normal control rats. Oral 
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administration of carvone as well as glyclazide to diabetic 
rats resulted in a significant reduction of protein bound 
hexose, hexosamine, fucose and sialic acid in plasma when 
compared to diabetic control rats. 
3.3. Effect of carvone on the levels of tissue glycoproteins 
   The levels of liver and kidney glycoprotein of control and 
experimental rats were shown in Tables 3 and 4. The level of 
hexose, hexosamine and fucose were significantly increased 
whereas the level of sialic acid was significantly decreased 
and those levels were brought back to near normal by 
treatment with carvone and glyclazid.
Table 3. 
Effect of carvone on liver glycoprotein levels in normal and experimental rats (mg/g 
defatted tissue).
Groups Hexose Hexosamine Fucose Sialic acid
Normal control 30.53依2.32* 13.25依1.01* 17.38依1.32* 11.02依0.84*
Normal + carvone (50 mg/kg) 28.79依2.20* 12.88依0.99* 16.93依2.61* 11.94依0.91*
Diabetic control 51.28依3.07† 24.73依2.03† 34.27依3.02†   4.27依0.33†
Diabetic +  carvone (50 mg/kg) 40.17依2.63‡ 19.28依1.48‡ 24.74依1.89‡   6.90依0.53‡
Diabetic + glyclazide (5 mg/kg) 36.94依2.83‡ 16.83依1.29‡ 22.58依1.73‡   8.07依0.62‡
Values are given as means依S.D. for six rats in each group. Values in a column not sharing 
a common superscript symbol (* -‡) differ significantly at P<0.05. Duncan’s Multiple 
Range Test (DMRT).
Table 4.
Effect of carvone on kidney glycoprotein levels in normal and experimental rats (mg/g 
defatted tissue).
Groups Hexose Hexosamine Fucose Sialic acid
Normal control 28.46依2.17* 16.92依1.29* 14.68依1.12*   9.47依0.72*
Normal + carvone (50 mg/kg) 27.62依2.11* 16.03依1.23* 14.06依1.08* 10.33依0.79*
Diabetic control 47.28依3.60
†
37.87依2.88
†
35.56依2.71
†
  4.87依0.37
†
Diabetic + carvone (50 mg/kg) 35.19依2.69
‡
22.75依1.74
‡
20.44依1.56
‡
  6.93依0.53
‡
Diabetic + glyclazide (5 mg/kg) 32.93依2.52
‡
20.55依1.57
‡
19.03依1.46
‡
  7.02依0.54
‡
Values are given as means依S.D. for six rats in each group. Values in a column not sharing 
a common superscript symbol (* -‡) differ significantly at P<0.05. Duncan’s Multiple 
Range Test (DMRT). 
4. Discussion
   Streptozotocin, a glucopyranose derivative of l-methyl-l 
nitrosourea, is unique for its diabetogenic potential in 
experimental animals and the presence of 2-deoxy-
D-glucose in its structure facilitates its preferential 
uptake into the pancreatic β-cells, probably via the low 
affinity glucose transporter, GLUT2[20].  Insulin is the sole 
hormone synthesized that lowers blood glucose, thereby 
playing important role in glucose metabolism[21]. In STZ 
administered diabetic rats, pancreatic β-cells are directly 
and specifically destroyed, and the resultant chronic 
hyperglycemia further damages the peripheral organs 
through increased oxidative stress and inflammation 
reaction, an effect called glucose toxicity[22]. These in turn 
potentiate the gradual loss of insulin sensitivity of peripheral 
organs during the pathogenesis of diabetes[23], which 
forms a vicious cycle for the progression and development 
of diabetes. In the present research, we found that oral 
administration of carvone for 30 d resulted in a significant 
reduction in plasma glucose concentrations and an increase 
in insulin levels in diabetic rats. The antidiabetic effect of 
carvone may be due to the increased release of insulin from 
the existing β-cells and/or regenerated β-cells of pancreas, 
restored insulin sensitivity or inhibition of intestinal 
absorption of glucose or enhanced the utilization of glucose 
by peripheral tissues. These results are in agreement 
with Ramachandran and Saravanan[24] who reported that 
administration of asiatic acid, a terpene to diabetic rats 
significantly decreased the glucose level to near normal.
   Glycation is a time-dependent, non-enzymatic reaction 
of sugars with proteins. The first step of glycation involving 
glucose requires a reversible, non-covalent binding 
interaction between glucose and select sites on the protein. 
A labile Schiff base may then form between the electrophilic 
carbonyl group of glucose and free nucleophilic amino 
groups on protein, followed by an Amadori rearrangement 
that yields a stable ketoamine adduct[25]. In uncontrolled 
or poorly controlled diabetes there is an increased 
glycosylation of a number of proteins including hemoglobin 
and crystalline of lens. Raised levels of glycoproteins 
in diabetics may also be a predictor of angiopathic 
complications.
   Generalized abnormalities in glycoprotein metabolism 
are observed in both naturally occurring and experimental 
diabetes[26]. Berenson et al[27] reported that STZ-induced 
diabetic rats exhibited a significant modification in the 
connective tissue macromolecule. Insulin has been shown to 
increase the incorporation of glucose in the rat submaxillary 
gland. The requirement of insulin for the biosynthesis of 
the carbohydrate moiety of mucoproteins from glucose is 
thus evident. But the deficiency of insulin during diabetes 
produces derangement of glycoprotein metabolism, 
resulting in the thickening of the basal membrane of 
pancreatic β-cells. The increased availability of glucose 
in the hyperglycemic state accelerates the synthesis of 
basement-membrane components, that is, glycoproteins[28]. 
Administration of carvone and glyclazid to diabetic rats 
significantly reversed these changes to near normal levels. 
The antihyperglycemic action of carvone, which is mediated 
via an enhancement of insulin action, as evidenced by the 
increased level of insulin in carvone treated diabetic rats, 
may be responsible for the reversal of plasma glycoprotein 
changes associated with diabetes.
   Glucose is the most important component for most living 
organisms. Hexoses of which glucose is one example evolved 
as energy sources critical for life. Protein bound hexoses 
in the cell membrane provides hydrophobic areas, whereas 
protein bound hexosamine provides cationic charges on 
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the cell membrane surface and make the membrane more 
polar. The elevated level of hexoses in diabetic rats may be 
associated with disturbances with carbohydrate metabolism. 
Treatment with carvone and glyclazid in diabetic rats 
showed significantly decreased hexoses due to improved 
glycemic control.
   Hexosamine a nitrogenous sugar in which an amino group 
replaces a hydroxyl group. It is an excellent precursor 
for use in the investigation of synthesis of plasma and 
tissue glycoproteins. The level of hexosamine, increased 
significantly in the plasma and tissues of diabetic rats 
which may be due to insulin deficiency, this leads to 
depressed utilization of glucose by insulin-dependent 
pathway, thereby enhancing the formation of hexose and 
hexosamine[29]. In diabetic rats treated with carvone and 
glyclazid showed significantly decreased hexosamines in the 
plasma and tissues when compared to diabetic rats, which 
could be due to improved glycemic control. Our results 
are find in line with the study of reduced hexosamine by 
improved glycemic control in S allylcysteine treated diabetic 
rats[30].
   Fucose is a member of the group of eight essential sugars 
the body requires for optimal function of cell-to-cell 
communication and its metabolism appears to be altered 
in various diseases such as diabetes mellitus[31]. A raise in 
fucose levels could be due to increased glycosylation in the 
diabetic state. Elevated levels of fucose in experimental 
diabetes were reported by other researchers[32]. In diabetic 
rats treated with carvone and glyclazid significantly lowered 
fucose levels, which might be due to increased secretion 
of insulin. Our results are finding in line with the study 
of reduced fucose by improved secretion of insulin in 
coumarin treated diabetic rats[33].
   Sialic acid is the terminal residue of the oligosaccharide 
side chain of glycoproteins and widely occurs in the 
exposed positions of molecules like hormones, enzymes 
and also on tissues[34]. Sialic acids play a role in cell-
cell recognition, protein targeting, protease resistance, 
conformational stabilization, adhesion and intracellular 
signaling events in biological systems. In diabetes mellitus, 
the tissue concentration of sialic acid was found to decrease 
significantly. The decrease in the content of sialic acid in 
tissues may be due to the utilization for the synthesis of 
fibronectin, which contains sialic acid residues in the core 
structure. The synthesis of fibronectin was also reported 
to increase significantly in various tissues of diabetic 
patients and rats. In our studies, a significant increase in 
total sialic acid levels in the plasma was observed when 
compared with the control group. Various factors might 
cause an elevation in the concentration of plasma sialic 
acid. Among these factors, the first is an increase in the 
synthesis of sialic acid in insulin-independent tissues, such 
as the liver and the brain, and the second is an increase in 
the activity of sialytransferase, which transfers the sialic 
acid residues to the glycolipids and glycoproteins[35]. In our 
study, administration of carvone and glyclazid increased the 
content of sialic acid in the tissues and decreased the sialic 
acid level in the plasma by enhancing the secretion insulin 
level. Insulin has been found to inhibit cytokine-induced 
acute phase protein synthesis in rat hepatic cell. This may, 
consequently, account for the decreased plasma sialic acid 
levels in the STZ-induced diabetic rats. Previous studies 
show that diosmin, produce the same effect in experimantal 
diabetic rats[36].
From the above f indings,  we conclude that  oral 
administration of carvone exhibits great potential as an 
antidiabetic agent by improving hyperglycemia in STZ-
induced diabetic rats. It also improved plasma insulin 
levels and decreased glycoprotein components in plasma, 
liver and kidney. This can be used as an effective indicator 
to show the beneficial effects of carvone in controlling the 
progression and complications of diabetes. 
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